SCHEMBL8292591

SCHEMBL8292591

COCCN(CCCc1cccc(F)c1)Cc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 7/20 0.54
TAAR1 Q96RJ0 1/20 0.47
LPAR1 Q92633 4/20 0.46
LPAR5 Q9H1C0 3/20 0.46
HTR2A P28223 1/20 0.45
HTR2C P28335 1/20 0.45
HTR2B P41595 1/20 0.45
MAOB P27338 1/20 0.43
OPRM1 P35372 3/20 0.43
OPRD1 P41143 2/20 0.43
OPRK1 P41145 2/20 0.43
CHRM2 P08172 1/20 0.42
HTR1A P08908 1/20 0.42
ADRA2A P08913 1/20 0.42
CHRM1 P11229 1/20 0.42
DRD1 P21728 1/20 0.42
SLC6A2 P23975 1/20 0.42
SLC6A4 P31645 1/20 0.42
ADRA1A P35348 1/20 0.42
DRD3 P35462 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8281042 0.80 MEN1 (0.51) OPRM1OPRD1OPRK1CALM1CAMKK2
SCHEMBL14376856 0.79 MAOB (0.56) BCHETAAR1MAOB
SCHEMBL14608016 0.78 TAAR1 (0.53) TAAR1MAOBSLC6A4SLC6A3
SCHEMBL8281044 0.76 MEN1 (0.51) CALM1CAMKK2
SCHEMBL14012776 0.76 ACKR3 (0.47) BCHECALM1CAMKK2
SCHEMBL24965971 0.75 TAAR1 (0.57) TAAR1MAOBSLC6A4SLC6A3
SCHEMBL12128568 0.75 TAAR1 (0.58) BCHETAAR1OPRM1OPRD1OPRK1
SCHEMBL9504529 0.74 MEN1 (0.48) HTR2AHTR2CHTR2BOPRM1OPRD1
SCHEMBL27621739 0.73 OPRK1 (0.55) BCHETAAR1OPRM1OPRD1OPRK1
SCHEMBL2260874 0.73 OPRK1 (0.59) TAAR1OPRM1OPRD1OPRK1DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005020975-A2 TREATMENT OF LEARNING DISABILITIES AND MOTOR SKILLS DISORDER WITH NOREPINEPHRINE REUPTAKE INHIBITORS ELI LILLY AND COMPANY (US) 2005-03-10 WO disclosed